John Lunger, Chief Patient Supply Officer at Adaptimmune Therapeutics PLC (ADAP), sold 4,440 shares at $1.86 ($8K) on 2023-01-17, disclosed to the SEC on 2023-01-17.
Seasonal sale ($8k) by Chief Patient Supply Officer — this insider has traded ADAP in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| ADAP | SELL | 2024-01-17 | $16K | — | Filing → |
| ADAP | SELL | 2024-01-12 | $8K | — | Filing → |
| ADAP | SELL | 2023-08-01 | $3K | — | Filing → |